$EXPO

Souri Shukri Jeries purchased $13K of EXPO

Souri Shukri Jeries (Group Vice President) purchased 184 shares of EXPONENT INC (EXPO) at $68.45 on 2026-09-18.

Original reporting
SEC EDGAR · Souri Shukri Jeries
Published Sep 22, 2026, 4:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 5:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EXPO
Neutral
high confidence
Mentioned
$EXPO
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EXPONeutralLow
01

Why it matters

The disclosed purchase is modest and unlikely to move the stock, but it adds to the insider activity record.

02

Market read

Routine insider purchase with limited trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed yet could make this purchase more meaningful.

Relevance 4/10Novelty 4/10Timing: filed today

Background

SEC Form 4 filings provide real-time insight into insider trading activity.

Company-level read

Ticker impact

$EXPONeutralHigh confidence
Context

Form 4 disclosed Group Vice President Souri Shukri Jeries bought 184 shares at $68.45, total $12.6K.

Expected impact

No significant move expected.

Evidence & confidence

Purchase size is trivial relative to float; insider is not a major holder.

Market effects

None; Exponent operates in engineering services with no sector-wide impact from this trade.

Limited to US markets; no broader regional effect.

Minimal; isolated insider transaction.

Counterpoint

Even small insider buys can signal confidence; monitor for future purchases.

Key entities

  • Exponent Inc

    US-listed engineering services firm (ticker EXPO).

  • Souri Shukri Jeries

    Group Vice President and officer of Exponent.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EXPOMedAI 8/10

Exponent (EXPO) Q2 2026 Earnings Call Transcript

Exponent, Inc. (EXPO) reported Q2 2026 net revenues of $148.9 million, up 12% from $132.9 million a year earlier, and net income of $29.4 million, up 11%. Diluted EPS was $0.60. Management raised FY 2026 revenue guidance to 9% to 10% growth and EBITDA margin to 27.8% to 28.1%, and authorized an additional $50 million for share repurchases.

$EXPOMedAI 8/10

Exponent Q2 Earnings Call Highlights

Exponent (NASDAQ:EXPO) reported Q2 EBITDA up 16% to $42.7 million, with EBITDA margin at 28.7% of net revenue versus 27.8% a year earlier. Billable hours rose 8% to about 390,000 and utilization increased to 74%. The company repurchased $67.4 million of stock and paid $14.8 million in dividends. It raised 2026 outlook for net revenue growth of 9% to 10%.